And another scoop: Two of FTI Consulting’s top economics experts in Europe have left to join Jonathan Orszag’s upstart rival ...

Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong listing, according to a regulatory filing made on Thursday.

Pony.ai, which raised USD 413 million in a US IPO, is now planning a Hong Kong listing to fuel further expansion. The company operates 250 robotaxis and is developing mass production models with ...

Jiangsu Hengrui Pharmaceuticals Co. has started taking investor orders for a Hong Kong listing that could raise as much as ...

Indian stock markets are likely to open on a positive note amid mixed global cues, and a lack of major domestic triggers ...

Shares of Etoro jumped 29% in their trading debut on Wednesday after the brokerage platform raised almost $310 million in an initial public offering. The stock’s closing price of $67 gave the company ...

HSBC HOLDINGS (00005.HK) announced that it had repurchased yesterday (14th) a total of 6.998 million shares of the company in ...

China-based Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a regulatory filing made on Thursday.

As we mark a decade of the Forbes 30 Under 30 Asia list, here’s a look at some of its most successful members to date.

Law firms may want to rethink the pivot from Hong Kong to the U.S., given Trump’s tariffs have made way for a potential thaw ...

World’s largest maker of electric-vehicle batteries could expand its IPO deal to as much as US$5.3 billion if several upsize options are exercised.

Charming Medical, which provides therapies and products inspired by traditional Chinese medicine, filed for an initial public offering of 1.6 million shares. The company said in a filing with the ...